• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Mixed; Dow Falls 100 Points

    10/2/23 9:59:19 AM ET
    $AWIN
    $FEMY
    $ICCM
    $INBS
    Aerospace
    Industrials
    Medical/Dental Instruments
    Health Care
    Get the next $AWIN alert in real time by email

    U.S. stocks traded mixed this morning, with the Dow Jones falling around 100 points on Monday.

    Following the market opening Monday, the Dow traded down 0.31% to 33,404.26 while the NASDAQ rose 0.38% to 13,269.83. The S&P 500 also fell, dropping, 0.09% to 4,284.19.

    Check This Out: Top 4 Consumer Stocks That May Explode This Month

     

    Leading and Lagging Sectors

    Communication services shares rose by 1% on Monday.

    In trading on Monday, utilities shares fell by 1.6%.

     

    Top Headline

    The S&P Global manufacturing PMI rose to 49.8 for September, compared to preliminary estimate of 48.9 and versus August’s reading of 47.9.

     

    Equities Trading UP

    AERWINS Technologies Inc. (NASDAQ:AWIN) shares shot up 101% to $0.2432 after the company said it is considering strategic alternatives for its non-core operations.

    Shares of IceCure Medical Ltd (NASDAQ:ICCM) got a boost, shooting 60% to $0.89 after the company said new data was presented at the European Society of Breast Imaging Scientific Meeting in Valencia, Spain by Lucía Graña-López, MD, PhD, principal investigator of the independent, non-sponsored study.

    Femasys Inc. (NASDAQ:FEMY) shares were also up, gaining 36% to $4.0635. Femasys shares jumped 46% on Friday after HC Wainwright maintained a Buy rating on the stock and raised its price target from $5 to $13.

     

    Equities Trading DOWN

    SmileDirectClub, Inc. (NASDAQ:SDC) shares dropped 61% to $0.16 after the company filed for Chapter 11 bankruptcy.

    Shares of Intelligent Bio Solutions Inc. (NASDAQ:INBS) were down 56% to $0.4638 as the company announced pricing of $4,000,000 underwritten public offering.

    Phoenix Motor Inc. (NASDAQ:PEV) was down, falling 24% to $0.8210 after the company signed a non-binding convertible bond term sheet of up to $300 million in funding with a California-based investor to support the potential acquisition opportunity of commercial electric vehicle assets for which Phoenix has submitted interest.

    Also Check This Out: These 3 Materials Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts

     

    Commodities

    In commodity news, oil traded up 0.1% to $90.83 while gold traded down 0.9% at $1,850.00.

    Silver traded down 3.8% to $21.60 on Monday while copper fell 1.8% to $3.6710.

     

    Euro zone

    European shares were lower today. The eurozone’s STOXX 600 fell 0.6% London’s FTSE 100 fell 0.6% while Spain’s IBEX 35 Index fell 0.1% The German DAX fell 0.4% French CAC 40 fell 0.4%, while Italy’s FTSE MIB Index fell 0.5%.

    The eurozone unemployment rate declined to 6.4% in August, the lowest on record, compared to revised 6.5% in the prior month, while manufacturing PMI was fell slightly to 43.4 in September from the prior month's level of 43.5.

    The S&P Global/CIPS UK’s manufacturing PMI rose slightly to 44.3 in September versus flash reading of 44.2. German manufacturing PMI was revised lower to 39.6 in September from a preliminary level of 39.8, while French manufacturing PMI rose to 44.2 in September from a preliminary estimate of 43.6.

     

    Asia Pacific Markets

    Asian markets closed lower on Monday, with Japan’s Nikkei 225 falling 0.31% and Australia’s S&P/ASX 200 falling 0.22%.

    The au Jibun Bank Japan manufacturing PMI was revised lower to 48.5 in September from a flash level of 48.6, while private home prices in Singapore rose by 0.5% quarter-on-quarter in the third quarter.

     

    Economics

    The S&P Global manufacturing PMI rose to 49.8 for September, compared to preliminary estimate of 48.9 and versus August’s reading of 47.9.

    Now Read This: Electronic Arts, Airbnb And 2 Other Stocks Insiders Are Selling

     

    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 108,752,790 cases with around 1,177,280 deaths. India confirmed a total of at least 44,998,830 cases and 531,930 deaths, while France reported over 40,138,560 COVID-19 cases with 167,640 deaths. In total, there were at least 696,038,990 cases of COVID-19 worldwide with more than 6,921,810 deaths.

    Get the next $AWIN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AWIN
    $FEMY
    $ICCM
    $INBS

    CompanyDatePrice TargetRatingAnalyst
    Femasys Inc.
    $FEMY
    11/20/2025$6.50Buy
    Laidlaw
    SmileDirectClub Inc.
    $SDC
    3/30/2022$2.00Hold → Sell
    Loop Capital
    SmileDirectClub Inc.
    $SDC
    3/2/2022$2.29 → $2.20Equal-Weight
    Morgan Stanley
    SmileDirectClub Inc.
    $SDC
    3/2/2022$5.00 → $3.00Equal-Weight
    Stephens & Co.
    IceCure Medical Ltd.
    $ICCM
    2/2/2022$5.65Buy
    Brookline Capital
    SmileDirectClub Inc.
    $SDC
    1/31/2022$2.29Equal-Weight
    Morgan Stanley
    SmileDirectClub Inc.
    $SDC
    1/25/2022Sell → Hold
    Craig Hallum
    SmileDirectClub Inc.
    $SDC
    1/7/2022$11.00 → $4.00Outperform
    Credit Suisse
    More analyst ratings

    $AWIN
    $FEMY
    $ICCM
    $INBS
    SEC Filings

    View All

    SEC Form 6-K filed by IceCure Medical Ltd.

    6-K - IceCure Medical Ltd. (0001584371) (Filer)

    4/22/26 5:28:16 PM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    SEC Form 6-K filed by IceCure Medical Ltd.

    6-K - IceCure Medical Ltd. (0001584371) (Filer)

    4/21/26 8:45:12 AM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    Intelligent Bio Solutions Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Filer)

    4/20/26 8:00:55 AM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    $AWIN
    $FEMY
    $ICCM
    $INBS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026

    ATLANTA, April 22, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today the commercial launch of FemaSeed Complete, a comprehensive fertility solution that enables OB/GYNs to perform first-line insemination entirely within their own practices. An estimated 10 million women in the United States experience infertility, yet fewer than half access care, and only a very small percentage ultimately undergo IVF. At the same time, U.S. fertility rates declined again in 2025 to a record low, underscoring the growing need for ear

    4/22/26 9:00:00 AM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense® Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025

    The Company's participation at the Society of Breast Imaging Symposium and other upcoming medical conferences are timely as commercial momentum acceleratesCryoablation cost analysis study from Massachusetts General Hospital featuring ProSense® demonstrated 50% reduction in cost vs. lumpectomy won SBI 2026 Abstract AwardCAESAREA, Israel, April 21, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced that it expects to report U.S. revenue of ProSense® systems and cryoprobes increased more than 30% in

    4/21/26 8:30:00 AM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified

    NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful completion of penetration testing as part of its upcoming FDA 510(k) submission. The testing identified no major vulnerabilities, verified the robustness of the Company's existing security infrastructure, and strengthened its regulatory submission to the FDA. In conjunction with the penetration testing, INBS implemented additional security upgrades to its drug testing technology. These upgrades include enhanced encrypted identification tags to ensure te

    4/17/26 8:30:00 AM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    $AWIN
    $FEMY
    $ICCM
    $INBS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Laidlaw initiated coverage on Femasys with a new price target

    Laidlaw initiated coverage of Femasys with a rating of Buy and set a new price target of $6.50

    11/20/25 8:06:38 AM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    SmileDirectClub downgraded by Loop Capital with a new price target

    Loop Capital downgraded SmileDirectClub from Hold to Sell and set a new price target of $2.00

    3/30/22 7:52:04 AM ET
    $SDC
    Medical/Dental Instruments
    Health Care

    Morgan Stanley reiterated coverage on SmileDirectClub with a new price target

    Morgan Stanley reiterated coverage of SmileDirectClub with a rating of Equal-Weight and set a new price target of $2.20 from $2.30 previously

    3/2/22 10:22:00 AM ET
    $SDC
    Medical/Dental Instruments
    Health Care

    $AWIN
    $FEMY
    $ICCM
    $INBS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Canning John Charles

    4 - FEMASYS INC (0001339005) (Issuer)

    4/1/26 5:31:32 PM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Canning John Charles

    3 - FEMASYS INC (0001339005) (Issuer)

    4/1/26 5:19:42 PM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Lee-Sepsick Kathy

    4 - FEMASYS INC (0001339005) (Issuer)

    3/27/26 5:00:26 PM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    $AWIN
    $FEMY
    $ICCM
    $INBS
    Leadership Updates

    Live Leadership Updates

    View All

    Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth

    ATLANTA, April 01, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today the appointment of John Canning as Chief Operating Officer. Mr. Canning is an accomplished medical device executive with more than 25 years of experience leading global operations and technology organizations within complex medical device companies. He brings a track record of scaling organizations, advancing product pipelines, and driving operational excellence across key functions to support commercial growth and product adoption. Prior to joining

    4/1/26 9:00:00 AM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    IceCure Appoints Meir Peleg as Chief Financial Officer

    Meir Peleg brings over 20 years of financial leadership and experience including with Nasdaq listed companiesIceCure intends to appoint Dr. Richard Fine as Medical Director CAESAREA, Israel, March 24, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced the appointment of Mr. Meir Peleg as its Chief Financial Officer ("CFO"), effective May 17, 2026. The appointment comes as IceCure is

    3/24/26 8:30:00 AM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors

    ATLANTA, March 18, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today the appointment of Kenneth D. Eichenbaum, M.D., M.S.E., to its Board of Directors. Dr. Eichenbaum is a board-certified anesthesiologist with clinical affiliations at Corewell Health William Beaumont University Hospital and Trinity Health Oakland Hospital, bringing deep clinical expertise and strategic insight developed through more than 20 years of evaluating biotechnology and medical device companies and advising investment firms. He completed a fel

    3/18/26 9:00:00 AM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    $AWIN
    $FEMY
    $ICCM
    $INBS
    Financials

    Live finance-specific insights

    View All

    IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense® Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025

    The Company's participation at the Society of Breast Imaging Symposium and other upcoming medical conferences are timely as commercial momentum acceleratesCryoablation cost analysis study from Massachusetts General Hospital featuring ProSense® demonstrated 50% reduction in cost vs. lumpectomy won SBI 2026 Abstract AwardCAESAREA, Israel, April 21, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced that it expects to report U.S. revenue of ProSense® systems and cryoprobes increased more than 30% in

    4/21/26 8:30:00 AM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update

    ATLANTA, March 31, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced its financial results for the year ended December 31, 2025 and provides a corporate update. Corporate Highlights from 4Q 2025 to date Initiated patient enrollment in the FINALE pivotal clinical trial evaluating FemBloc, advancing toward U.S. approval.Appointed Kenneth D. Eichenbaum, M.D., M.S.E., to the Board of Directors, strengthening leadership and strategic oversight.FemBloc permanent birth control system achieved certification under the Medical Device Single Au

    3/31/26 4:05:00 PM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    IceCure Reports 2025 Full Year Financial & Operational Results

    Record 4th quarter and full year sales of $1.3 million and $3.4 million, respectivelyStrong commercial momentum for ProSense® in the U.S. and globally following FDA clearance in low-risk breast cancer and medical society recommendations 30 hybrid commercial-clinical sites to be added for FDA approved post-marketing study in addition to growing pipeline of potential commercial customersIceCure Applies to Expand Regulatory Approval in Canada for ProSense® Cryoablation to Include the Treatment of Low-Risk Breast Cancer  Conference call to be held today at 11:00 am Eastern TimeCAESAREA, Israel, March 17, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the

    3/17/26 8:30:00 AM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    $AWIN
    $FEMY
    $ICCM
    $INBS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by IceCure Medical Ltd.

    SC 13G/A - IceCure Medical Ltd. (0001584371) (Subject)

    11/14/24 9:38:43 PM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Intelligent Bio Solutions Inc.

    SC 13G/A - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Subject)

    11/14/24 7:16:17 PM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Intelligent Bio Solutions Inc.

    SC 13G - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Subject)

    11/14/24 4:31:30 PM ET
    $INBS
    Medical/Dental Instruments
    Health Care